Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.

Serra M, Pasello M, Manara MC, Scotlandi K, Ferrari S, Bertoni F, Mercuri M, Alvegard TA, Picci P, Bacci G, Smeland S.

Int J Oncol. 2006 Dec;29(6):1459-68.

PMID:
17088985
[PubMed - indexed for MEDLINE]
2.

Tumor size and prognosis in aggressively treated osteosarcoma.

Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, Bielack S, Heise U, Jurgens H, Treuner J, Romanowski R, Exner U, Kotz R, Winkler K.

J Clin Oncol. 1996 Mar;14(3):848-58. Review.

PMID:
8622033
[PubMed - indexed for MEDLINE]
3.

[Progress and stagnation in chemotherapy protocols for primary osteosarcoma].

Delépine N, Alkallaf S, Cornille H, Markowska B, Delépine G.

Ann Med Interne (Paris). 2003 Feb;154(1):12-24. Review. French.

PMID:
12746655
[PubMed - indexed for MEDLINE]
4.

Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma, according to treatment protocols SSG II, SSG VIII, ISG/SSG I, SSG IV and SSG IX.

Holmström T, Böhling T, Akerman M, Willén H, Stenwig E, Bertoni F.

Acta Orthop Scand Suppl. 1999 Jun;285:27-9. Review.

PMID:
10429618
[PubMed - indexed for MEDLINE]
5.

Delaying surgery with chemotherapy for osteosarcoma of the extremities.

Bielack SS, Machatschek JN, Flege S, Jürgens H.

Expert Opin Pharmacother. 2004 Jun;5(6):1243-56. Review.

PMID:
15163270
[PubMed - indexed for MEDLINE]
6.

Doxorubicin: role in the treatment of osteosarcoma.

Blaney SM, Smith MA, Grem JL.

Cancer Treat Res. 1993;62:55-73. Review. No abstract available.

PMID:
8096760
[PubMed - indexed for MEDLINE]
7.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
8.

Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.

Smeland S, Wiebe T, Böhling T, Brosjö O, Jonsson K, Alvegård TA.

Acta Orthop Scand Suppl. 2004 Apr;75(311):92-8. Review. No abstract available.

PMID:
15188671
[PubMed - indexed for MEDLINE]
9.

Proteins expressed in osteosarcoma and serum levels as prognostic factors.

Trieb K, Kotz R.

Int J Biochem Cell Biol. 2001 Jan;33(1):11-7. Review.

PMID:
11167128
[PubMed - indexed for MEDLINE]
10.

Management of osteosarcoma.

Whelan J, Seddon B, Perisoglou M.

Curr Treat Options Oncol. 2006 Nov;7(6):444-55. Review.

PMID:
17032557
[PubMed - indexed for MEDLINE]
11.

Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience.

Bruland ØS, Bauer H, Alvegaard T, Smeland S.

Cancer Treat Res. 2009;152:309-18. doi: 10.1007/978-1-4419-0284-9_16. Review.

PMID:
20213398
[PubMed - indexed for MEDLINE]
12.

Therapy for osteosarcoma: where do we go from here?

Chou AJ, Geller DS, Gorlick R.

Paediatr Drugs. 2008;10(5):315-27. Review.

PMID:
18754698
[PubMed - indexed for MEDLINE]
13.

Development of acute myeloid leukemia after chemotherapy for osteosarcoma.

Kawai A, Sugihara S, Naito N, Ozaki T, Isu K, Hatae Y, Inoue H.

Clin Orthop Relat Res. 2001 Oct;(391):239-46. Review.

PMID:
11603675
[PubMed - indexed for MEDLINE]
14.

A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma.

Li YG, Geng X.

Eur J Cancer Care (Engl). 2010 May;19(3):313-6. doi: 10.1111/j.1365-2354.2008.00970.x. Epub 2009 Aug 26. Review.

PMID:
19709164
[PubMed - indexed for MEDLINE]
15.

Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.

Sakamoto A, Iwamoto Y.

Rev Recent Clin Trials. 2008 Sep;3(3):228-31. Review.

PMID:
18782081
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Osteogenic sarcoma in the Rothmund-Thomson syndrome.

Leonard A, Craft AW, Moss C, Malcolm AJ.

Med Pediatr Oncol. 1996 Apr;26(4):249-53. Review.

PMID:
8600336
[PubMed - indexed for MEDLINE]
17.

Chemotherapy resistance in osteosarcoma: current challenges and future directions.

Chou AJ, Gorlick R.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1075-85. Review.

PMID:
16831079
[PubMed - indexed for MEDLINE]
18.

Current aspects of the pathology of osteosarcoma.

Grundmann E, Roessner A, Ueda Y, Schneider-Stock R, Radig K.

Anticancer Res. 1995 May-Jun;15(3):1023-32. Review.

PMID:
7645921
[PubMed - indexed for MEDLINE]
19.

New targets and approaches in osteosarcoma.

Gill J, Ahluwalia MK, Geller D, Gorlick R.

Pharmacol Ther. 2013 Jan;137(1):89-99. doi: 10.1016/j.pharmthera.2012.09.003. Epub 2012 Sep 14. Review.

PMID:
22983152
[PubMed - indexed for MEDLINE]
20.

Primary osteogenic sarcoma of the kidney--a case report and review of the literature.

Leventis AK, Stathopoulos GP, Boussiotou AC, Papadimitriou KP, Kehayas PC.

Acta Oncol. 1997;36(7):775-7. Review. No abstract available.

PMID:
9490100
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk